BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 38720365)

  • 1. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration.
    Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L
    Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pan-cancer analysis of the predictive biomarker for the CDKN3.
    Chen Y; Li D; Sha K; Zhang X; Liu T
    Eur J Med Res; 2024 May; 29(1):272. PubMed ID: 38720365
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Islam SS; Karakas B; Aboussekhra A; Noman ASM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying key genes related to inflammasome in severe COVID-19 patients based on a joint model with random forest and artificial neural network.
    Ou H; Fan Y; Guo X; Lao Z; Zhu M; Li G; Zhao L
    Front Cell Infect Microbiol; 2023; 13():1139998. PubMed ID: 37113134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of risk factors on early cancer evolution.
    Weeden CE; Hill W; Lim EL; Grönroos E; Swanton C
    Cell; 2023 Apr; 186(8):1541-1563. PubMed ID: 37059064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
    Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer.
    Islam MA; Hossen MB; Horaira MA; Hossen MA; Kibria MK; Reza MS; Tuly KF; Faruqe MO; Kabir F; Mahumud RA; Mollah MNH
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial biology of cancer evolution.
    Seferbekova Z; Lomakin A; Yates LR; Gerstung M
    Nat Rev Genet; 2023 May; 24(5):295-313. PubMed ID: 36494509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF7 promotes preadipocyte proliferation via activation of the Akt signaling pathway by
    Jia Z; Jin Z; Shao S; Xu H; Li W; Khan M; Wang W; Zhang W; Sun Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1486-1496. PubMed ID: 36269137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 regulates alternative splicing in prostate cancer.
    Del Giudice M; Foster JG; Peirone S; Rissone A; Caizzi L; Gaudino F; Parlato C; Anselmi F; Arkell R; Guarrera S; Oliviero S; Basso G; Rajan P; Cereda M
    Cell Rep; 2022 Sep; 40(13):111404. PubMed ID: 36170835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer.
    Lu S; Hua J; Liu J; Wei M; Liang C; Meng Q; Zhang B; Yu X; Wang W; Xu J
    BMC Cancer; 2022 Jul; 22(1):804. PubMed ID: 35864471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
    Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
    Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma.
    Abdel-Tawab MS; Fouad H; Othman AM; Eid RA; Mohammed MA; Hassan A; Reyad HR
    PLoS One; 2022; 17(4):e0265184. PubMed ID: 35446856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomics analysis and benchmark concentration estimating-based in vitro test with IOSE80 cells to unveil the mode of action for female reproductive toxicity of bisphenol A at human-relevant levels.
    Li X; Ni M; Xiong W; Tian L; Yang Z; Zhang L; Chen J
    Ecotoxicol Environ Saf; 2022 Jun; 237():113523. PubMed ID: 35429799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming.
    Li M; Che N; Jin Y; Li J; Yang W
    Onco Targets Ther; 2022; 15():299-311. PubMed ID: 35388272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma
    Dai W; Fang S; Cai G; Dai J; Lin G; Ye Q; Miao H; Chen M; Tan X; Chen N; Liu X; Li M
    J Int Med Res; 2020 Jul; 48(7):300060520936879. PubMed ID: 32721244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1.
    Li WH; Zhang L; Wu YH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3614-3623. PubMed ID: 32329836
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.